Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MONOPOLY ESSENTIALS • • • • • One firm Unique product: no close substitutes Industry demand equals firm demand Demand slopes down Marginal Revenue is below demand and slopes down twice as fast Profit Maximizing of Monopolist • If the MC > MR raise price and reduce sales. MC will fall and MR will rise, Profits will rise. • If the MC < MR lower price and increase sales. MC will rise and MR will fall. Profits will rise. • If MC = MR you are doing the best you can. Tricks and traps to using the monopolist’s diagram • Find the profit maximising quantity by finding the intersection of MR and MC. • Find the profit maximising price by finding the highest quantity at which the firm can sell that quantity. • You can read the price by going up vertically from the best quantity and finding the best price on the demand curve. • TRAP: giving MR as the price Profit Maximising Price, Quantity and Profit Monopolists can make Losses LOSSES • If the ATC curve is everywhere above the Demand curve, a profit is not possible. • Produce where MR = MC so long as P>AVC so loss is less than or equal to fixed costs • Urban transit systems are often in this situation LONG-RUN EQUILIBRIUM LONG-RUN EQUILIBRIUM • Because there is no entry in a monopoly, profits can persist in the long-run. EFFICIENCY AND MONOPOLY • Allocative efficiency is never achieved: • P > MR = MC. • The price, what people are willing to pay, is always greater than the cost of one more unit. • We are always willing to give up more than what must be given up to obtain one more unit of the good EFFICIENCY AND MONOPOLY • Productive efficiency is achieved only by chance. • If price is greater than ATC, the firm may produce at an output that causes ATC to be greater than or less than the minimum • Because firms do not enter or leave the industry, the number of firms in the industry doesn’t adjust until each firm is the ideal size. EQUITY AND MONOPOLY • Monopolist can earn excessive profits at the expense of the consumer • Monopoly power permits these firms to be nasty capitalists who systematically exploit the consumer. Regulation of Monopoly • Economists regulate a monopoly to achieve allocative efficiency • The price is set where the Marginal Cost curve intersects the Demand curve • As a result P = MC, producing allocative efficiency Marginal Cost Pricing Marginal Cost Pricing REGULATION • Regulating so that P=MC sometimes results in a profit (but less than if unregulated) • Regulating so that P=MC sometimes results in a loss. • Profits should be taxed away. • Firms must receive subsidies to cover losses REGULATING DRUG COMPANIES Unregulated Drug Companies • Monopoly caused by government patent • MC is very low. Manufacturing one more unit of drug is usually fairly cheap. • Demand is very inelastic. The price must be very high before MR>0 and TR is at a maximum. • The firm is very far from allocative or productive efficiency. Much more should be produced. REGULATING DRUG COMPANIES • Firm has very high fixed costs due to research and development • If price equals the cost of manufacturing one more unit, the fixed costs are unlikely to be covered by the price • Firms will make a loss • No one would develop new drugs Average Cost Pricing AVERAGE COST PRICING • Setting Price so that the firm makes only a normal return (P=ATC) is politically easier. • Measuring costs is difficult. The firms may know, but the firms have an incentive to lie. • Developing drugs is risky. What is a large enough return to induce firms to take the risks? The firms will tell you it is very high. CANADA VS. THE U.S. • Canada regulates drug companies to restrain profits. Whether they have reached prices that give only a fair return is debatable. Prices are much lower than in the U.S. where they are unregulated. • U.S. firms have more incentive to develop new drugs. • The American public has a large incentive to buy drugs in Canada.